Persistence of Immunity to Varicella in Children with Leukemia Immunized with Live Attenuated Varicella Vaccine

New England Journal of Medicine

Volumn 320, Issue 14, 1989, Pages 892-897

  Gershon, Anne A ^a   Steinberg, Sharon P ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; CHICKENPOX; CHILD; CHILDHOOD LEUKEMIA; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RASH; SEROCONVERSION; VACCINATION;

EID: 0024598119     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198904063201403     Document Type: Article

References (19)

1. Feldman S, Lott L. Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80: 465–72.
2. Preblud SR. Varicella: complications and costs. Pediatrics 1986; 78: 728–35.
3. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288–90.
4. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children. N Engl J Med 1984; 310: 1409–15.
5. Gershon AA, Steinberg SP, LaRussa P, et al. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988; 158: 132–7.
6. Gershon AA, Steinberg SP, Gelb L, et al. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 1984; 252: 355–62.
7. Lawrence R, Gershon AA, Holzman R, Steinberg SP, NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988; 318: 543–8.
8. Brunell PA, Taylor-Wiedman J, Geiser CF, Frierson L, Lydick E. Risk of herpes zoster in children with leukemia: varicella vaccine compared with history of chickenpox. Pediatrics 1986; 77: 53–6.
9. Oka T, Iseki K, Oka R, Sakuma S, Yoshioka H, Takahashi M. Evaluation of varicella vaccine in childhood leukemia: observation over 6 years. Biken J 1984; 27: 103–9.
10. Gershon AA, Steinberg SP, Gelb L, NIAID Varicella Vaccine Collaborative Study Group. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics 1986; 78: 757–62.
11. Marwick C. Varicella vaccine licensing in 18 to 24 months. JAMA 1987; 258: 3215–6.
12. Williams V, Gershon A, Brunell PA. Serologic response to varicella–zoster membrane antigens measured by indirect immunofluorescence. J Infect Dis 1974; 134: 669–72.
13. Martin JH, Dohner DE, Wellinghoff WJ, Gelb LD. Restriction endonuclease analysis of varicella–zoster vaccine virus and wild-type DNAs. J Med Virol 1982; 9: 69–76.
14. Plotkin SA. Varicella vaccine: a point of decision. Pediatrics 1986; 78: 705–7.
15. Ross AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962; 267: 369–76.
16. Bogger-Goren S, Baba K, Hurley P, Yabuuchi H, Takahashi M, Ogra PL. Antibody response to varicella–zoster virus after natural or vaccine-induced infection. J Infect Dis 1982; 146: 260–5.
17. Asano Y, Albrecht P, Vujcic LK, Quinnan GV Jr, Kawakami K, Takahashi M. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays. Pediatrics 1983; 72: 291–4.
18. Dubey L, Steinberg SP, LaRussa P, Oh P, Gershon AA. Western blot analysis of antibody to varicella–zoster virus. J Infect Dis 1988; 157: 882–8.
19. Asano Y, Nagai T, Miyata T, et al. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine. Pediatrics 1985; 75: 667–71.